Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoChange DetectedA new platform revision tag v3.6.3 was added, replacing v3.6.2, indicating a software update rather than changes to study content.SummaryDifference0.0%

- Check12 days agoChange DetectedNew recruitment, sponsor, and study-document links were added to the Study Details page. Items include BMS Clinical Trial Patient Recruiting, BMS Clinical Trial Information, Mirati Therapeutics Inc., and a PDF of the Study Protocol and Statistical Analysis Plan, along with IPD data-sharing notes.SummaryDifference100%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedEnrollment status updated to indicate no recruitment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision label updated to v3.6.0, with a formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, indicating a small revision to the page's history. No substantive content changes are implied.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, representing a small version metadata update to the study record.SummaryDifference0.0%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.